Related references
Note: Only part of the references are listed.MicroRNAs Regulate Expression of Oncogenes
Frank J. Slack
CLINICAL CHEMISTRY (2013)
Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients
Marco Tomasetti et al.
CLINICAL BIOCHEMISTRY (2012)
The Clinical Effect of the Dual-Targeting Strategy Involving PI3K/AKT/mTOR and RAS/MEK/ERK Pathways in Patients with Advanced Cancer
Toshio Shimizu et al.
CLINICAL CANCER RESEARCH (2012)
MiR-126 Acts as a Tumor Suppressor in Pancreatic Cancer Cells via the Regulation of ADAM9
Shin Hamada et al.
MOLECULAR CANCER RESEARCH (2012)
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Kim J. Png et al.
NATURE (2012)
MMP7 and activation of IGF1R A new insight into anti-EGFR therapeutic resistance in metastatic colorectal cancer
Shinya Ohashi et al.
CANCER BIOLOGY & THERAPY (2011)
miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5
Edit Miko et al.
FEBS LETTERS (2011)
Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form
C. Mongaret et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models
Tamara Terzian et al.
JOURNAL OF PATHOLOGY (2011)
Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2
Ni Zhu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
MicroRNA-126 Inhibits SOX2 Expression and Contributes to Gastric Carcinogenesis
Takeshi Otsubo et al.
PLOS ONE (2011)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
William H. Chappell et al.
ONCOTARGET (2011)
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Andrea L. Kasinski et al.
NATURE REVIEWS CANCER (2011)
Hematopoietic differentiation: a coordinated dynamical process towards attractor stable states
Nadia Felli et al.
BMC SYSTEMS BIOLOGY (2010)
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma
A. K. Kivisaari et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Secreted and Membrane-Bound Isoforms of Protease ADAM9 Have Opposing Effects on Breast Cancer Cell Migration
Jessica L. Fry et al.
CANCER RESEARCH (2010)
Osteopontin: An Effector and an Effect of Tumor Metastasis
L. A. Shevde et al.
CURRENT MOLECULAR MEDICINE (2010)
Oncogenic mutant forms of EGFR: Lessons in signal transduction and targets for cancer therapy
Gur Pines et al.
FEBS LETTERS (2010)
Matrix Metalloproteinase-7 and ADAM-12 (a Disintegrin and Metalloproteinase-12) Define a Signaling Axis in Agonist-Induced Hypertension and Cardiac Hypertrophy
Xiang Wang et al.
CIRCULATION (2009)
Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology
Franziska Buback et al.
EXPERIMENTAL DERMATOLOGY (2009)
MicroRNA 223-dependent expession of LMO2 regulates normal erythropoiesis
Nadia Felli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Validation of HB-EGF and amphiregulin as targets for human cancer therapy
Fusanorl Yotsumoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The cell growth suppressor, mir-126, targets IRS-1
Jin Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Activated Gα13 Impairs Cell Invasiveness through p190RhoGAP-Mediated Inhibition of RhoA Activity
Ruben A. Bartolome et al.
CANCER RESEARCH (2008)
The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms
Federica Felicetti et al.
CANCER RESEARCH (2008)
Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: A new molecular target therapy for gastric cancer
Takaya Shimura et al.
CLINICAL CANCER RESEARCH (2008)
The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis
Shusheng Wang et al.
DEVELOPMENTAL CELL (2008)
The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers
Chunguang Guo et al.
GENES CHROMOSOMES & CANCER (2008)
Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells
Alla Musiyenko et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
Distinct microRNA expression profiles in acute myeloid leukemia with common translocations
Zejuan Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
An intermediary role of proHB-EGF shedding in growth factor-induced c-Myc gene expression
Daisuke Nanba et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Models and mechanisms in malignant melanoma
Cara L. Benjamin et al.
MOLECULAR CARCINOGENESIS (2007)
Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma
K. Kawasaki et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma
M. Sensi et al.
ONCOGENE (2006)
ADAM-9 expression and regulation in human skin melanoma and melanoma cell lines
P Zigrino et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Osteopontin expression correlates with melanoma invasion
YW Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Ectodomain shedding of membrane-anchored heparin-binding EGF like growth factor and subcellular localization of the Cc-terminal fragment in the cell cycle
F Toki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?
B Wielockx et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3
S Mochizuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
'Advanced' generation lentivirruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo
D Bonci et al.
GENE THERAPY (2003)
Integrin expression in colon cancer ells is regulated by the cytoplasmic domain of the β6 integrin subunit
J Niu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma
E Alvino et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)
R Agnihotri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)